Arbutus Biopharma Corp - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 9, 2016

Attached files

file filename
EX-10.78 - EXHIBIT 10.78 - Arbutus Biopharma Corpexhibit1078lizhowardea.htm
EX-10.79 - EXHIBIT 10.79 - Arbutus Biopharma Corpexhibit1079monsantoamendme.htm
EX-32.1 - EXHIBIT 32.1 - Arbutus Biopharma Corpexhibit321.htm
EX-31.1 - EXHIBIT 31.1 - Arbutus Biopharma Corpexhibit311.htm
EX-23.1 - EXHIBIT 23.1 - Arbutus Biopharma Corpexhibit231kpmgconsent.htm
EX-10.81 - EXHIBIT 10.81 - Arbutus Biopharma Corpexhibit1081monsantoamendme.htm
EX-31.2 - EXHIBIT 31.2 - Arbutus Biopharma Corpexhibit312.htm
EX-10.80 - EXHIBIT 10.80 - Arbutus Biopharma Corpexhibit1080monsantoamendme.htm
EX-32.2 - EXHIBIT 32.2 - Arbutus Biopharma Corpexhibit322.htm
10-K - 10-K 2015 - Arbutus Biopharma Corparbutus10k2015.htm

Exhibit 21.1
 
Arbutus Biopharma Corporation
 
List of Subsidiaries
 
Name
Date on which the entity
became Arbutus’ wholly
owned sub
Jurisdiction
Protiva Biotherapeutics Inc.
May 30, 2008
British Columbia, Canada
Arbutus Biopharma Inc.
Mar. 4, 2015
Delaware, United States of America


Stock widget

Investing forum

Arbutus Biopharma Corp Reports